Literature DB >> 8386339

Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state.

P J Harrison1, A W Procter, T Exworthy, G W Roberts, A Najlerahim, A J Barton, R C Pearson.   

Abstract

Heat shock proteins (hsps) are involved in the response by cells to stress including hyperthermia, hypoxia and injury. Previous work has demonstrated expression of messenger RNA (mRNA) encoding 70 kDa hsps (hsp70) in animal brain in response to stimuli such as these. We have used in situ hybridization histochemistry to assess the distribution and quantity of a specific hsp70 (called hsx70) mRNA in frontal cortex and cerebellum from normal and demented patients whose pre-mortem course had been documented. In cortex, hsx70 mRNA was concentrated over pia mater and glia but was also present over neurons; in cerebellum, hsx70 mRNA was prominent over granule cells but absent from Purkinje cells. Detection of hsx70 mRNA did not correlate with pre-mortem factors such as pyrexia or coma. Increased hsx70 mRNA was found in frontal cortex white matter in Alzheimer's disease and in a mixed group of other neurodegenerative disorders. No changes occurred in cerebellum. The data provide further evidence for altered hsp gene expression in dementia, and support the existence of a stress response occurring in brains affected by such diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386339     DOI: 10.1111/j.1365-2990.1993.tb00400.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

1.  Twenty-first century brain banking. Processing brains for research: the Columbia University methods.

Authors:  Jean Paul G Vonsattel; Maria Pilar Del Amaya; Christian E Keller
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

2.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

3.  Analysis of Laser Therapy Effects on Squamous Cell Carcinoma Patients: A System Biology Study.

Authors:  Vahid Mansouri; Mostafa Rezaei-Tavirani; Mohammad-Mehdi Zadeh-Esmaeel; Sina Rezaei-Tavirani; Mohammadreza Razzaghi; Farshad Okhovatian; Mohammad Rostami-Nejad; Alireza Ahmadzade
Journal:  J Lasers Med Sci       Date:  2019-12-01

Review 4.  Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

5.  Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90).

Authors:  Lawrence C S Tam; Anna-Sophia Kiang; Matthew Campbell; James Keaney; G Jane Farrar; Marian M Humphries; Paul F Kenna; Pete Humphries
Journal:  Hum Mol Genet       Date:  2010-09-02       Impact factor: 6.150

6.  Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia.

Authors:  K Renkawek; G J Bosman; W W de Jong
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Selective postmortem degradation of inducible heat shock protein 70 (hsp70) mRNAs in rat brain.

Authors:  S Pardue; A L Zimmerman; M Morrison-Bogorad
Journal:  Cell Mol Neurobiol       Date:  1994-08       Impact factor: 5.046

Review 8.  Stress proteins: their role in the normal central nervous system and in disease states, especially multiple sclerosis.

Authors:  G Birnbaum
Journal:  Springer Semin Immunopathol       Date:  1995

Review 9.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

Review 10.  The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies.

Authors:  Subhabrata Chaudhury; Bradley M Keegan; Brian S J Blagg
Journal:  Med Res Rev       Date:  2020-08-25       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.